New hope in fight against 'Lorenzo's Oil' disease
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A dramatic breakthrough in the possible treatment of childhood diseases of the nervous system – including the disorder featured in the film Lorenzo's Oil – was announced by scientists in America yesterday.
For the first time, researchers appear to have cured a similar disease in mice by the injection of human stem cells designed to re-build the sheath of fatty tissue surrounding nerve cells that is lost in inherited diseases such as adrenoleukodystrophy, which last week claimed the life of Lorenzo Odone, whose battle against the disease was dramatised in the film.
The myelin sheath performs the vital role of insulating nerve impulses; the possibility of re-building it offers hope to thousands of children with a host of gene disorders such as Tay-Sachs and Krabbe disease, as well as adults suffering from multiple sclerosis.
Although the research is still at the earliest stages, the scientists believe its results are a further demonstration of the power of stem-cell treatments.
The laboratory mice in the study all suffered from an inherited condition that would normally kill them within about 20 weeks of birth. However, some of the mice that received the treatment not only lived for several months after that, but actually improved to the point of seeming to be cured.
"It's extremely exciting to think about not only treating but actually curing a disease," said Professor Steven Goldman, of the University of Rochester Medical Centre in New York, who led the research team. "Unfortunately, right now, we can do little more besides tell parents to prepare for their kids to die," said Professor Goldman, whose study is published in the journal Cell Stem Cell.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments